Tumor Biology

, Volume 37, Issue 3, pp 3469–3477 | Cite as

Genetic variants in the ITGB6 gene is associated with the risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy

  • Minxiao Yi
  • Yang Tang
  • Bo Liu
  • Qianxia Li
  • Xiao Zhou
  • Shiying Yu
  • Shengling Fu
  • Yixin Cai
  • Xianglin Yuan
Original Article


The αvβ6 integrin is a cell surface adhesion molecule that plays critical roles in the injury and inflammation processes. We hypothesized that polymorphisms in αvβ6 integrin genes (ITGAV and ITGB6) might be associated with the risk of radiation pneumonitis (RP) in lung cancer patients treated with thoracic radiation. We genotyped three potentially functional αvβ6 integrin single-nucleotide polymorphisms (rs1839123 and rs4129787 in ITGAV, and rs4665162 in ITGB6) and found that the genotypes of rs4665162 single-nucleotide polymorphisms were predictors of RP development (for grade ≥2 RP, HR = 1.505, 95 % CI 1.069–2.119, P = 0.019; for grade ≥3 RP, HR = 3.006, 95 % CI 1.431–6.313, P = 0.004). Our results showed that AG/GG genotypes of ITGB6 rs4665162 gene were associated with a higher risk of RP in patients with lung cancer receiving radiotherapy and thus may serve as a reliable predictor of RP. Further studies will be needed to confirm these findings.


ITGB6 Single-nucleotide polymorphism Radiation pneumonitis Lung cancer 


Compliance with ethical standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.


This study was funded by National Natural Science Foundation of China (grant numbers 81272492 and 81472921).

Conflicts of interest


Informed consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. United States.CrossRefPubMedGoogle Scholar
  2. 2.
    Cannon DM, Mehta MP, Adkison JB, Khuntia D, Traynor AM, Tome WA, et al. Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer. J Clin Oncol. 2013;31:4343–8. United States.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Yin M, Liao Z, Liu Z, Wang L-E, O’Reilly M, Gomez D, et al. Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy. Cancer. 2012;118:528–35. United States.CrossRefPubMedGoogle Scholar
  4. 4.
    Provatopoulou X, Athanasiou E, Gounaris A. Predictive markers of radiation pneumonitis. Anticancer Res. 2008;28:2421–32. Greece.PubMedGoogle Scholar
  5. 5.
    Pu X, Wang L, Chang JY, Hildebrandt MAT, Ye Y, Lu C, et al. Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancer. Clin Pharmacol Ther. 2014;96:609–15. United States.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Mak RH, Alexander BM, Asomaning K, Heist RS, Liu C, Su L, et al. A single-nucleotide polymorphism in the methylene tetrahydrofolate reductase (MTHFR) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy. Cancer. 2012;118:3654–65. United States.CrossRefPubMedGoogle Scholar
  7. 7.
    Yuan X, Liao Z, Liu Z, Wang L-E, Tucker SL, Mao L, et al. Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol. 2009;27:3370–8. United States.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999;96:319–28. United States.CrossRefPubMedGoogle Scholar
  9. 9.
    Sugimoto K, Kudo M, Sundaram A, Ren X, Huang K, Bernstein X, et al. The alphavbeta6 integrin modulates airway hyperresponsiveness in mice by regulating intraepithelial mast cells. J Clin Invest. 2012;122:748–58. United States.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe R, Chou P, et al. Therapeutic targeting of integrin alphavbeta6 in breast cancer. J Natl Cancer Inst. 2014;106:pii: dju169. United States.CrossRefGoogle Scholar
  11. 11.
    Pi L, Robinson PM, Jorgensen M, Oh S-H, Brown AR, Weinreb PH, et al. Connective tissue growth factor and integrin alphavbeta6: a new pair of regulators critical for ductular reaction and biliary fibrosis in mice. Hepatology. 2015;61:678–91. United States.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Vujaskovic Z, Thrasher BA, Jackson IL, Brizel MB, Brizel DM. Radioprotective effects of amifostine on acute and chronic esophageal injury in rodents. Int J Radiat Oncol Biol Phys. 2007;69:534–40. United States.CrossRefPubMedGoogle Scholar
  13. 13.
    Breuss JM, Gallo J, DeLisser HM, Klimanskaya IV, Folkesson HG, Pittet JF, et al. Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci. 1995;108(Pt 6):2241–51. England.PubMedGoogle Scholar
  14. 14.
    Weinacker A, Ferrando R, Elliott M, Hogg J, Balmes J, Sheppard D. Distribution of integrins alpha v beta 6 and alpha 9 beta 1 and their known ligands, fibronectin and tenascin, in human airways. Am J Respir Cell Mol Biol. 1995;12:547–56. United States.CrossRefPubMedGoogle Scholar
  15. 15.
    Puthawala K, Hadjiangelis N, Jacoby SC, Bayongan E, Zhao Z, Yang Z, et al. Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis. Am J Respir Crit Care Med. 2008;177:82–90. United States.CrossRefPubMedGoogle Scholar
  16. 16.
    Shakiba E, Tavilani H, Goodarzi MT, Kiani A, Pourmotabbed T, Vaisi-Raygani A. The ITGAV-rs3911238 polymorphism is associated with disease activity in rheumatoid arthritis. Iran J Allergy Asthma Immunol. 2014;13:356–63. Iran Google Scholar
  17. 17.
    Lee SK, Kim M-H, Cheong JY, Cho SW, Yang S-J, Kwack K. Integrin alpha V polymorphisms and haplotypes in a Korean population are associated with susceptibility to chronic hepatitis and hepatocellular carcinoma. Liver Int. 2009;29:187–95. England.CrossRefPubMedGoogle Scholar
  18. 18.
    Qi L, Cornelis MC, Kraft P, Stanya KJ, Linda Kao WH, Pankow JS, et al. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet. 2010;19:2706–15. England.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Poulter JA, Brookes SJ, Shore RC, Smith CEL, Abi Farraj L, Kirkham J, et al. A missense mutation in ITGB6 causes pitted hypomineralized amelogenesis imperfecta. Hum Mol Genet. 2014;23:2189–97. England.CrossRefPubMedGoogle Scholar
  20. 20.
    Van Meerbeeck JP, Fennell DA, De Ruysscher DKM. Small-cell lung cancer. Lancet. 2011;378:1741–55. (London, England). England.CrossRefPubMedGoogle Scholar
  21. 21.
    Goldstraw P, Ball D, Jett JR, Le Chevalier T, Lim E, Nicholson AG, et al. Non-small-cell lung cancer. Lancet. 2011;378:1727–40. (London, England). England.CrossRefPubMedGoogle Scholar
  22. 22.
    Schallenkamp JM, Miller RC, Brinkmann DH, Foote T, Garces YI. Incidence of radiation pneumonitis after thoracic irradiation: dose-volume correlates. Int J Radiat Oncol Biol Phys. 2007;67:410–6. United States.CrossRefPubMedGoogle Scholar
  23. 23.
    Kong F-MS, Wang S. Nondosimetric risk factors for radiation-induced lung toxicity. Semin Radiat Oncol. 2015;25:100–9. United States.CrossRefPubMedGoogle Scholar
  24. 24.
    Chan C, Lang S, Rowbottom C, Guckenberger M, Faivre-Finn C. Intensity-modulated radiotherapy for lung cancer: current status and future developments. J Thorac Oncol. 2014;9:1598–608. United States.CrossRefPubMedGoogle Scholar
  25. 25.
    Shi M, Zhu J, Wang R, Chen X, Mi L, Walz T, et al. Latent TGF-beta structure and activation. Nature. 2011;474:343–9. England.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Park J, Ryu S-H, Choi EK, Ahn SD, Park E, Choi K-C, et al. SKI2162, an inhibitor of the TGF-beta type I receptor (ALK5), inhibits radiation-induced fibrosis in mice. Oncotarget. 2015;6:4171–9. United States.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Li J, Mu S, Mu L, Zhang X, Pang R, Gao S. Transforming growth factor-beta-1 is a serum biomarker of radiation-induced pneumonitis in esophageal cancer patients treated with thoracic radiotherapy: preliminary results of a prospective study. Onco Targets Ther. 2015;8:1129–36. New Zealand.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Niu X, Li H, Chen Z, Liu Y, Kan M, Zhou D, et al. A study of ethnic differences in TGFbeta1 gene polymorphisms and effects on the risk of radiation pneumonitis in non-small-cell lung cancer. J Thorac Oncol. 2012;7:1668–75. United States.CrossRefPubMedGoogle Scholar
  29. 29.
    Alsbeih G, Al-Harbi N, Al-Hadyan K, El-Sebaie M, Al-Rajhi N. Association between normal tissue complications after radiotherapy and polymorphic variations in TGFB1 and XRCC1 genes. Radiat Res. 2010;173:505–11. United States.CrossRefPubMedGoogle Scholar
  30. 30.
    Zhang L, Yang M, Bi N, Ji W, Wu C, Tan W, et al. Association of TGF-beta1 and XPD polymorphisms with severe acute radiation-induced esophageal toxicity in locally advanced lung cancer patients treated with radiotherapy. Radiother Oncol. 2010;97:19–25. Ireland.CrossRefPubMedGoogle Scholar
  31. 31.
    Henderson NC, Arnold TD, Katamura Y, Giacomini MM, Rodriguez JD, McCarty JH, et al. Targeting of alphav integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med. 2013;19:1617–24. United States.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Minxiao Yi
    • 1
  • Yang Tang
    • 1
  • Bo Liu
    • 1
  • Qianxia Li
    • 1
  • Xiao Zhou
    • 1
  • Shiying Yu
    • 1
  • Shengling Fu
    • 2
  • Yixin Cai
    • 2
  • Xianglin Yuan
    • 1
  1. 1.Department of Oncology, Tongji HospitalHuazhong University of Science and TechnologyWuhanChina
  2. 2.Department of Thoracic Surgery, Tongji HospitalHuazhong University of Science and TechnologyWuhanChina

Personalised recommendations